More new substances OKd for approval in first half, says EMA
This article was originally published in Scrip
Executive Summary
The number of products recommended for EU approval by the European Medicines Agency in the first half of 2013 rose substantially in the first half of 2013 compared with the 2012 period. There was a notable increase in the tally of new active substances, of which four were OKd under special regulatory procedures for speeding up access to innovative medicines.